"Section 3(d) of the Indian Patent Act forbids the patenting of new forms of known drugs unless the new form significantly enhances efficacy and yields therapeutic benefits. This interpretation removes the incentive for improvements to existing therapies, which are often not optimal."
"Incremental innovation plays an important role in improving health outcomes, frequently becoming best in class and first line therapies. These developments allow physicians to treat the specific needs of diverse patients effectively."
"Incremental innovations provide for more convenient extended-release dosing and formulations that do not require refrigeration, which are valuable characteristics in developing country settings."
The Supreme Court of India's strict interpretation of patent law limits patenting of new drug forms unless they significantly enhance efficacy. This discourages incremental innovation, which is vital for improving existing therapies and health outcomes. Incremental innovations can lead to better dosing options and formulations that are crucial for diverse patient needs. They are especially important in developing countries, where convenient and stable drug formulations are necessary. The current patent law may ultimately restrict access to essential medicines and hinder pharmaceutical advancements.
Read at IPWatchdog.com | Patents & Intellectual Property Law
Unable to calculate read time
Collection
[
|
...
]